Michael Gelband’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.33M Sell
310,541
-178,922
-37% -$1.38M 0.02% 622
2026
Q1
$3.12M Buy
+489,463
New +$3.41M 0.02% 605
2025
Q4
Sell
-561,953
Closed -$3.09M 1819
2025
Q3
$3.09M Buy
+561,953
New +$2.75M 0.03% 577
2025
Q2
Sell
-28,472
Closed -$190K 1751
2025
Q1
$190K Buy
+28,472
New +$216K ﹤0.01% 1306
2024
Q2
Sell
-158,823
Closed -$980K 1773
2024
Q1
$980K Buy
+158,823
New +$1.07M 0.01% 952
2023
Q4
Sell
-121,013
Closed -$831K 1791
2023
Q3
$831K Buy
+121,013
New +$981K 0.01% 1023

Other funds holding LFST

Michael Gelband's LFST Position: Q2 2026 in Review

Michael Gelband reduced its Lifestance Health (LFST) stake by 37% in Q2 2026, selling an estimated $1.38M and leaving 310,541 shares worth $3.33M. The position accounts for 0.02% of the portfolio, ranked #622.

Michael Gelband first reported a position in LFST in Q3 2023 and has held it in 6 quarters since. 285 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Michael Gelband held 310,541 shares of Lifestance Health worth $3.33M as of Q2 2026.
  • Michael Gelband sold 178,922 Lifestance Health shares in Q2 2026, an estimated $1.38M.
  • Lifestance Health made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #622 holding.
  • Michael Gelband first reported a position in Lifestance Health in Q3 2023 and has held it in 6 quarters since.
  • 285 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.